Why Arena Pharmaceuticals' Q2 Results Don't Matter
Arena Pharmaceuticals (NASDAQ: ARNA) has made investors happy campers so far in 2020. Its shares are up more than 40%. The company also reported some good news from its pipeline earlier this year and even enjoyed a boost from positive data for a rival's drug.
But when Arena announced its second-quarter results after the market closed on Wednesday, investors basically yawned. Why? The Q2 results really don't matter.
Source Fool.com